{
    "id": "dbpedia_1985_0",
    "rank": 64,
    "data": {
        "url": "https://www.crukscotlandinstitute.ac.uk/careers/postdoctoral-fellows/106-research/the-beatson-institute-research-groups.html",
        "read_more_link": "",
        "language": "en",
        "title": "The Beatson Institute Research Groups",
        "top_image": "https://crukscotlandinstitute.b-cdn.net/favicons/favicon-32x32.png",
        "meta_img": "https://crukscotlandinstitute.b-cdn.net/favicons/favicon-32x32.png",
        "images": [
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Ahmad_23_-_266_Beatson_Lab_Groups_000270_resized.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Bird_23_-_266_Beatson_Lab_Groups_000094.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Blyth_23_-_266_Beatson_Lab_Groups_000046.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Bryant_23_-_266_Beatson_Lab_Groups_000070.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Bushell_23_-_278_Beatson_Institute_Lab_Groups_0086.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Cagan_23_-_278_Beatson_Institute_Lab_Groups_0110.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Carlin_23_-_266_Beatson_Lab_Groups_000222.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Coffelt_23_-_279_Beatson_Institute_Lab_Photos_0441.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Cordero_23_-_278_Beatson_Institute_Lab_Groups_0074.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Cowling_23_-_266_Beatson_Lab_Groups_000198.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Diamantopoulou.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Froeling_23_-_266_Beatson_Lab_Groups_000110.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Fu_23_-_266_Beatson_Lab_Groups_000168.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Gammage_23_-_266_Beatson_Lab_Groups_000073.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Huang_head_069.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Inman_23_-_266_Beatson_Lab_Groups_000100.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Le_Quesne_23_-_266_Beatson_Lab_Groups_000191.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Leung_23_-_278_Beatson_Institute_Lab_Groups_0089.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Lewis_23_-_266_Beatson_Lab_Groups_000250.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/MacVicarTom_2023.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Maslowski_23_-_266_Beatson_Lab_Groups_000233.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/MillerC23_-_266_Beatson_Lab_Groups_000322.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Morton_23_-_278_Beatson_Institute_Lab_Groups_0045.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Murphy_23_-_266_Beatson_Lab_Groups_000336.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Norman_23_-_266_Beatson_Lab_Groups_000126.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Portal_23_-_266_Beatson_Lab_Groups_000034.jpeg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Roberts_23_-_266_Beatson_Lab_Groups_000154.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Ryan_23_-_266_Beatson_Lab_Groups_000084.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/SansomO.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Steele_23_-_266_Beatson_Lab_Groups_000010.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Tait_23_-_266_Beatson_Lab_Groups_000298.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Tardito_23_-_266_Beatson_Lab_Groups_000062.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Zanivan_23_-_266_Beatson_Lab_Groups_000040.jpeg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Le_Quesne_23_-_266_Beatson_Lab_Groups_000191.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/beatson_research_group/LeQuesne_Group_23_-_266_Beatson_Lab_Groups_000186.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Cordero_23_-_278_Beatson_Institute_Lab_Groups_0074.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/University_of_Glasgow-_Colour.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/Wellcome_Trust_logo.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/ChineseScholarship_logo.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/beatson_research_group/Cordero_23_-_278_Beatson_Institute_Lab_Groups_0066.jpg",
            "https://crukscotlandinstitute.b-cdn.net/media/djmediatools/cache/1-lab-celebration-photos/700x450-toheight-90-cordero_group_photos_1.jpg",
            "https://crukscotlandinstitute.b-cdn.net/media/djmediatools/cache/1-lab-celebration-photos/700x450-toheight-90-cordero_group_photos_2.jpg",
            "https://crukscotlandinstitute.b-cdn.net/media/djmediatools/cache/1-lab-celebration-photos/700x450-toheight-90-cordero_group_photos_3.jpg",
            "https://crukscotlandinstitute.b-cdn.net/media/djmediatools/cache/1-lab-celebration-photos/700x450-toheight-90-cordero_group_photos_4.jpg",
            "https://crukscotlandinstitute.b-cdn.net/components/com_djmediatools/layouts/horizontalSwipe/images/prev.png",
            "https://crukscotlandinstitute.b-cdn.net/components/com_djmediatools/layouts/horizontalSwipe/images/next.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Steele_23_-_266_Beatson_Lab_Groups_000010.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/UKRI.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/Tenovus_logo.png",
            "https://crukscotlandinstitute.b-cdn.net/images/Picture1.png_mcnab_new_logo.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/beatson_research_group/Steele_Group_23_-_266_Beatson_Lab_Groups_000006.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Froeling_23_-_266_Beatson_Lab_Groups_000110.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/University_of_Glasgow-_Colour.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Cagan_23_-_278_Beatson_Institute_Lab_Groups_0110.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/NIH.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/Royal_Society_logo.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/beatson_research_group/Cagan_Group_23_-_278_Beatson_Institute_Lab_Groups_0115.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/MacVicarTom_2023.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/Lab_members/VJX_picture.jpeg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/Lab_members/Marilia_Pic.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/Lab_members/IMG_6659.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Cowling_23_-_266_Beatson_Lab_Groups_000198.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/LOGO_ERC_2020.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/Wellcome_Trust_logo.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/UKRI_MR_Council-Logo_Horiz-RGB.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/ChineseScholarship_logo.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/logos/charity_logos/Royal_Society_logo.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/beatson_research_group/Cowling_Group_23_-_266_Beatson_Lab_Groups_000202.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Maslowski_23_-_266_Beatson_Lab_Groups_000233.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Diamantopoulou.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/leaders/Group_Leaders_2023/Fu_23_-_266_Beatson_Lab_Groups_000168.jpg",
            "https://crukscotlandinstitute.b-cdn.net/templates/beatson/img/layout/email.png",
            "https://crukscotlandinstitute.b-cdn.net/images/Focal_adhesion_Jamie_Whitelaw.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/stories/general_images/Melanoma_cells_2.jpg",
            "https://crukscotlandinstitute.b-cdn.net/images/logos/cruk-scotland-institute-transparent.png",
            "https://crukscotlandinstitute.b-cdn.net/images/beatson_insta.png",
            "https://crukscotlandinstitute.b-cdn.net/images/beatson_twitter.png",
            "https://crukscotlandinstitute.b-cdn.net/images/Large-CRUK_logo-light-background-primary-RGB.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "en",
        "meta_favicon": "//crukscotlandinstitute.b-cdn.net/templates/beatson/favicon.ico",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "Recent Publications\n\n2024\n\nClaudio Quiros A, Coudray N, Yeaton A, Yang X, Liu B, Le H, Chiriboga L, Karimkhan A, Narula N, Moore DA, Park CY, Pass H, Moreira AL, Le Quesne J, Tsirigos A, Yuan K. Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unannotated pathology slides. Nat Commun. 2024;15(1):4596.\n\nPan X, AbdulJabbar K, Coelho-Lima J, Grapa AI, Zhang H, Cheung AHK, Baena J, Karasaki T, Wilson CR, Sereno M, Veeriah S, Aitken SJ, Hackshaw A, Nicholson AG, Jamal-Hanjani M, Swanton C, Yuan Y, Le Quesne J, Moore DA. The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma. Nat Cancer. 2024.\n\nWilliams HL, Poulain N, Powley I, Martinelli S, Bielik R, Leslie H, Nixon C, Wilson CR, Sereno M, He Z, Officer-Jones L, Ballantyne F, Pennie R, Wood CS, Lewis DY, Jamieson NB, Le Quesne J. Spatial resolution of transcriptomic plasticity states underpinning lethal morphologies in lung adenocarcinoma. bioRxiv. 2024:2024.2006.2011.598228.\n\n2023\n\nHatthakarnkul P, Ammar A, Pennel KAF, Officer-Jones L, Cusumano S, Quinn JA, Matly AAM, Alexander PG, Hay J, Andersen D, Lynch G, van Wyk HC, Maka N, McMillan DC, Le Quesne J, Thuwajit C, Edwards J. Protein expression of S100A2 reveals it association with patient prognosis and immune infiltration profile in colorectal cancer. J Cancer. 2023;14:1837-1847.\n\nHendrix E, Andrijes R, Boora U, Kaur A, Bundred JR, Officer-Jones L, pennie r, Powley I, Zayer A, Heilig R, Westrip CAE, Fletcher SF, Eaton CD, Kennedy TJ, Piasecka S, Fischer R, Smerdon SJ, Quesne JL, Coleman ML. A protein hydroxylase couples epithelial membrane biology to nucleolar ribosome biogenesis. bioRxiv. 2023;Volume:2023.2003.2015.532818.\n\nFarahmand P, Gyuraszova K, Rooney C, Raffo-Iraolagoitia XL, Jayasekera G, Hedley A, Johnson E, Chernova T, Malviya G, Hall H, Monteverde T, Blyth K, Duffin R, Carlin LM, Lewis D, Le Quesne J, MacFarlane M, Murphy DJ. Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. Frontiers in Toxicology. 2023;5.\n\nFrankell AM, Dietzen M, Al Bakir M, Lim EL, Karasaki T, Ward S, Veeriah S, Colliver E, Huebner A, Bunkum A, Hill MS, Grigoriadis K, Moore DA, Black JRM, Liu WK, Thol K, Pich O, Watkins TBK, Naceur-Lombardelli C, Cook DE, Salgado R, Wilson GA, Bailey C, Angelova M, Bentham R, Martínez-Ruiz C, Abbosh C, Nicholson AG, Le Quesne J, Biswas D, Rosenthal R, Puttick C, Hessey S, Lee C, Prymas P, Toncheva A, Smith J, Xing W, Nicod J, Price G, Kerr KM, Naidu B, Middleton G, Blyth KG, Fennell DA, Forster MD, Lee SM, Falzon M, Hewish M, Shackcloth MJ, Lim E, Benafif S, Russell P, Boleti E, Krebs MG, Lester JF, Papadatos-Pastos D, Ahmad T, Thakrar RM, Lawrence D, Navani N, Janes SM, Dive C, Blackhall FH, Summers Y, Cave J, Marafioti T, Herrero J, Quezada SA, Peggs KS, Schwarz RF, Van Loo P, Miedema DM, Birkbak NJ, Hiley CT, Hackshaw A, Zaccaria S, Jamal-Hanjani M, McGranahan N, Swanton C. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature. 2023; 616: 525–533\n\nKarasaki T, Moore DA, Veeriah S, Naceur-Lombardelli C, Toncheva A, Magno N, Ward S, Bakir MA, Watkins TBK, Grigoriadis K, Huebner A, Hill MS, Frankell AM, Abbosh C, Puttick C, Zhai H, Gimeno-Valiente F, Saghafinia S, Kanu N, Dietzen M, Pich O, Lim EL, Martínez-Ruiz C, Black JRM, Biswas D, Campbell BB, Lee C, Colliver E, Enfield KSS, Hessey S, Hiley CT, Zaccaria S, Litchfield K, Birkbak NJ, Cadieux EL, Demeulemeester J, Van Loo P, Adusumilli PS, Tan KS, Cheema W, Sanchez-Vega F, Jones DR, Rekhtman N, Travis WD, Hackshaw A, Marafioti T, Salgado R, Le Quesne J, Nicholson AG, McGranahan N, Swanton C, Jamal-Hanjani M. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx. Nat Med. 2023; 29: 833–845\n\nLaing S, Kruspig B, Shaw R, Officer-Jones L, Edwards S, McKinven D, Hsieh Y-C, Powley I, Brady N, Pennie R, Kwan R, Lima A, Myrta S, Periyasamy M, Dye IC, Nixon C, Clark G, Junttila MR, Maddalo D, Miller C, Ali S, Fuchter MJ, Nickles D, Kirschner K, Brown RB, Quesne JL, Strathdee D, Coffelt SB, Roberts E, Murphy DJ. ERBB signalling contributes to immune evasion in KRAS-driven lung adenocarcinoma. bioRxiv. 2023:2023.2007.2024.550274.\n\nMay S, Müller M, Livingstone CR, Skalka GL, Walsh PJ, Nixon C, Hedley A, Shaw R, Clark W, Voorde JV, Officer-Jones L, Ballantyne F, Powley IR, Drake TM, Kiourtis C, Keith A, Rocha AS, Tardito S, Sumpton D, Le Quesne J, Bushell M, Sansom OJ, Bird TG. Absent expansion of AXIN2+ hepatocytes and altered physiology in Axin2CreERT2 mice challenges the role of pericentral hepatocytes in homeostatic liver regeneration. J Hepatol. 2023; 78: 1028-1036\n\nMoore M, Pardo L, Mitchell L, Schmidt T, May S, Mueller M, Strathdee D, Bryson S, Hodge K, Lilla S, Zanivan S, Waldron J, McGarry L, Peter-Durairaj R, Kanellos G, Nixon C, Ballantyne F, LeQuesne J, Sansom OJ, Bird T, Bushell M, Norman JC. The eIF4A2 negative regulator of mRNA translation promotes extracellular matrix deposition to accelerate hepatocellular carcinoma initiation. bioRxiv. 2023;Volume:2023.2008.2016.553544.\n\nRomán-Fernández A, Mansour MA, Kugeratski FG, Anand J, Sandilands E, Galbraith L, Rakovic K, Freckmann EC, Cumming EM, Park J, Nikolatou K, Lilla S, Shaw R, Strachan D, Mason S, Patel R, McGarry L, Katoch A, Campbell KJ, Nixon C, Miller CJ, Leung HY, Le Quesne J, Norman JC, Zanivan S, Blyth K, Bryant DM. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function. Sci Adv. 2023;9:eabq1858.\n\nSchmidt T, Dabrowska A, Waldron JA, Hodge K, Koulouras G, Gabrielsen M, Munro J, Tack DC, Harris G, McGhee E, Scott D, Carlin Leo M, Huang D, Le Quesne J, Zanivan S, Wilczynska A, Bushell M. eIF4A1-dependent mRNAs employ purine-rich 5’UTR sequences to activate localised eIF4A1-unwinding through eIF4A1-multimerisation to facilitate translation. Nucleic Acids Research. 2023; 51: 1859–1879\n\nThunnissen E, Beasley MB, Borczuk A, Dacic S, Kerr KM, Lissenberg-Witte B, Minami Y, Nicholson AG, Noguchi M, Sholl L, Tsao MS, Le Quesne J, Roden AC, Chung JH, Yoshida A, Moreira AL, Lantuejoul S, Pelosi G, Poleri C, Hwang D, Jain D, Travis WD, Brambilla E, Chen G, Botling J, Bubendorf L, Mino-Kenudson M, Motoi N, Chou TY, Papotti M, Yatabe Y, Cooper W. Defining Morphologic Features of Invasion in Pulmonary Nonmucinous Adenocarcinoma With Lepidic Growth: A Proposal by the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol. 2023;18:447-462.\n\nWaldron JA, Kanellos G, Smith RCL, Knight JRP, Munro J, Alexandrou C, Vlahov N, Pardo-Fernandez L, Moore M, Gillen SL, Strathdee D, Stevenson D, Warrander FC, Gilroy K, Nixon C, Cadden B, Powley I, Officer-Jones L, Ballantyne F, Hay J, Pennel K, Edwards J, Campbell AD, Ridgway RA, Coffelt SB, Norman J, Quesne JL, Bushell M, Sansom OJ. eIF4A1 is essential for reprogramming the translational landscape of Wnt-driven colorectal cancers. bioRxiv. 2023:2023.2011.2010.566546.\n\nZhang H, AbdulJabbar K, Moore DA, Akarca A, Enfield K, Jamal-Hanjani M, Raza SEA, Veeriah S, Salgado R, McGranahan N, Le Quesne J, Swanton C, Marafioti T, Yuan Y. Spatial positioning of immune hotspots reflects the interplay between B and T cells in lung squamous cell carcinoma. Cancer Res. 2023; 83:1410–1425.\n\nZhang H, AbdulJabbar K, Grunewald T, Akarca AU, Hagos Y, Sobhani F, Lecat CSY, Patel D, Lee L, Rodriguez-Justo M, Yong K, Ledermann JA, Le Quesne J, Hwang ES, Marafioti T, Yuan Y. Self-supervised deep learning for highly efficient spatial immunophenotyping. EBioMedicine. 2023;95:104769.\n\n2022\n\nKamata T, Al Dujaily E, Alhamad S, So TY, Margaritaki O, Giblett S, Pringle JH, Le Quesne J, Pritchard C. Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironment. Dis Model Mech. 2022;15:dmm049148\n\n2021\n\nGhaddar N, Wang S, Woodvine B, Krishnamoorthy J, van Hoef V, Darini C, Kazimierczak U, Ah-Son N, Popper H, Johnson M, Officer L, Teodósio A, Broggini M, Mann KK, Hatzoglou M, Topisirovic I, Larsson O, Le Quesne J, Koromilas AE. The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer. Nat Commun. 2021;12(1):4651.\n\nGrosso S, Marini A, Gyuraszova K, Voorde JV, Sfakianos A, Garland GD, Tenor AR, Mordue R, Chernova T, Morone N, Sereno M, Smith CP, Officer L, Farahmand P, Rooney C, Sumpton D, Das M, Teodósio A, Ficken C, Martin MG, Spriggs RV, Sun XM, Bushell M, Sansom OJ, Murphy D, MacFarlane M, Le Quesne JPC, Willis AE. The pathogenesis of mesothelioma is driven by a dysregulated translatome. Nat Commun. 2021;12:4920.\n\nKnight JRP, Alexandrou C, Skalka GL, Vlahov N, Pennel K, Officer L, Teodosio A, Kanellos G, Gay DM, May-Wilson S, Smith EM, Najumudeen AK, Gilroy K, Ridgway RA, Flanagan DJ, Smith RCL, McDonald L, MacKay C, Cheasty A, McArthur K, Stanway E, Leach JD, Jackstadt R, Waldron JA, Campbell AD, Vlachogiannis G, Valeri N, Haigis KM, Sonenberg N, Proud CG, Jones NP, Swarbrick ME, McKinnon HJ, Faller WJ, Le Quesne J, Edwards J, Willis AE, Bushell M, Sansom OJ. MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. Cancer Discov. 2021;11(5):1228-1247.\n\nNtala C, Salji M, Salmond J, Officer L, Teodosio AV, Blomme A, McGhee EJ, Powley I, Ahmad I, Kruithof-de Julio M, Thalmann G, Roberts E, Goodyear CS, Jamaspishvili T, Berman DM, Carlin LM, Le Quesne J, Leung HY. Analysis of Prostate Cancer Tumor Microenvironment Identifies Reduced Stromal CD4 Effector T-cell Infiltration in Tumors with Pelvic Nodal Metastasis. Eur Urol Open Sci. 2021;29:19-29.\n\nPhatak V, von Grabowiecki Y, Janus J, Officer L, Behan C, Aschauer L, Pinon L, Mackay H, Zanivan S, Norman JC, Kelly M, Le Quesne J, Muller PAJ. Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane. Cell Death Dis. 2021;12(2):207.\n\n2020\n\nAbdulJabbar K, Ahmed Raza SE, Rosenthal R, Jamal-Hanjani M, Veeriah S, Akarca A, Lund T, Moore DA, Salgado R, Al Bakir M, Zapata L, Hiley CT, Officer L, Sereno M, Smith CR, Loi S, Hackshaw A, Marafioti T, Quezada SA, Nicholas McGranahan N, Le Quesne J, TRACERx Consortium, Swanton C, Yuan Y. Geospatial Immune Variability Illuminates Differential Evolution of Lung Adenocarcinoma Nature Medicine. 2020; 26(7): 1054-62\n\nCurtin N, Bányai K, Thaventhiran J, Le Quesne J, Helyes Z, Bai P. Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS? Br J Pharmacol. 2020; 177(16): 3635-45\n\nOfficer LK, Andreou KE, Teodósio AV, He Z, Le Quesne JP. Automated Co-in Situ Hybridization and Immunofluorescence Using Archival Tumor Tissue Methods Mol Biol 2020; 2148: 245-56\n\nSereno M, Smith C, Baena J, He Z, Das M, Hastings R, Rake G, Fennell D, Nakas A, Moore D, Le Quesne J. Inclusion of multiple high-risk histopathological criteria improves the prediction of adjuvant chemotherapy efficacy in lung adenocarcinoma Journal of Pathology, 2020; 78: 838-848\n\nZhang YZ, Brambilla C, Molyneaux PL, Rice A, Robertus JL, Jordan S, Lim E, Lang-Lazdunski L, Begum S, Dusmet M, Anikin V, Beddow E, Finch J, Asadi N, Popat S, Le Quesne J, Husain AN, Cookson WO, Moffatt MF, Nicholson AG. Presence of pleomorphic features but not growth patterns improves prognostic stratification of epithelioid malignant pleural mesothelioma by 2-tier nuclear grade Histopathology 2020; 77(3): 423-36\n\n2019\n\nRakhit C, Trigg RM, Le Quesne J, Kelly M, Shaw JA, Pritchard C, Martins LM. Early detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNA Dis Model Mech, 2019 Feb 12;12(2):dmm036863\n\nRosenthal R, Cadieux EL, Salgado R, Bakir MA, Moore DA, Hiley CT, Lund T, Tanić M, Reading JL, Joshi K, Henry JY, Ghorani E, Wilson GA, Birkbak NJ, Jamal-Hanjani M, Veeriah S, Szallasi Z, Loi S, Hellmann MD, Feber A, Chain B, Herrero J, Quezada SA, Demeulemeester J, Van Loo P, Beck S, McGranahan N, Swanton C; TRACERx consortium. Neoantigen-directed immune escape in lung cancer evolution Nature 2019; 567: 479-85.\n\nThis landmark study of the primary tumour tissues from the TraceRx cohort shows how tumours evolve under natural selection to evade the human immune system.\n\nMoore D, Das M, Baena Acevedo J, Sinnadurai S, Sereno M, Smith C, McSweeney A, Su X, Officer L, Jones C, Dudek K, Guttery D, Spriggs R, Le Quesne J. In situ growth in early lung adenocarcinoma may represent precursor growth or invasive clone outgrowth - a clinically relevant distinction Modern Pathology 2019; 32: 1095-105\n\nFercoq F, Remion E, Frohberger SJ, Vallarino-Lhermitte N, Hoerauf A, Le Quesne J, Landmann F, Hübner MP, Carlin LM, Martin C. IL-4 receptor dependent expansion of lung CD169+ macrophages in microfilaria-driven inflammation PLoS Negl Trop Dis. 2019; 13(8): e7691\n\nOfficer LK, Andreou KE, Teodósio AV, He Z, Le Quesne J. Automated co-in situ hybridization and immunofluorescence using archival tumour tissue Methods Mol Biol. 2020; 2148: 245-56\n\nWilczynska A, Gillen S, Schmidt T, Meijer H, Jukes-Jones R, Langlais C, Kopra K, Lu W-T, Godfrey J, Hawley B, Hodge K, Zanivan S, Cain K, Le Quesne J, Bushell M. eIF4A2 drives repression of translation at initiation by Ccr4-Not through purine-rich motifs in the 5’UTR Genome Biology 2019 Dec 2;20(1):262\n\nWaldron J, Tack D, Ritchey L, Wilczynska A, Turro E, Bevilacqua P, Assmann S, Bushell M, Le Quesne J. mRNA structural elements immediately upstream of the start codon dictate dependence upon eIF4A helicase activity Genome Biology 2019 Dec 30;20(1):300\n\nAl-Dujaily E, Baena J, Das M, Sereno M, Smith C, Kamata T, Officer L, Pritchard C, Le Quesne J. Reduced pro-tumourigenic tumour-associated macrophages with statin use in premalignant human lung adenocarcinoma JNCI Cancer Spectrum 2019 Dec 13;4(2):pkz101\n\n2018\n\nKolluri KK, Alifrangis C, Kumar N, Ishii Y, Price S, Michaut M, Williams S, Barthorpe S, Lightfoot H, Busacca S,Sharkey A, Yuan Z, Sage EK, Vallath S, Le Quesne J, Tice DA, Alrifai D, von Karstedt S, Montinaro A, Guppy N, Waller DA, Nakas A, Good R, Holmes A, Walczak H, Fennell DA, et al. Loss of functional BAP1 augments sensitivity to TRAIL in cancer cells eLife 2018 Jan 18;7:e30224\n\nWaldron J, Raza F, Le Quesne J. eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes Nucleic Acids Research 2018 Apr 6;46(6):3075-87\n\nMackay H, Moore D, Hall C, Birkbak N, Jamal-Hanjani M, Karim S, Pathak V, Pinon L, MortonJ, Swanton C, Muller P, Le Quesne J. Genomic instability in mutant p53 cancer cells upon entotic engulfment Nature Communications 2018 Aug 3;9(1):3070\n\nArce Vargas F, Furness AJS, Litchfield K, Joshi K, Rosenthal R, Ghorani E, Solomon I, Lesko MH, Ruef N, Roddie C, Henry JY, Spain L, Ben Aissa A, Georgiou A, Wong YNS, Smith M, Strauss D, Hayes A, Nicol D, O'Brien T, Mårtensson L, Ljungars A, Teige I, Frendéus B; TRACERx Melanoma; TRACERx Renal; TRACERx Lung consortia, et al. Fc effector function contributes to the activity of human anti-CTLA-4 antibodies Cancer Cell 2018 Apr 9;33(4):649-663.e4\n\nLazarus KA, Hadi F, Zambon E, Bach K, Santolla M-F, Watson JK, Correia LL, Das M, Ugur R, Pensa S, Becker L, Campos LS, Ladds G, Pentao L, Evan G, McCaughan F, Le Quesne J, Lee J-H, Calado D, Khaled WT. BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous cell carcinoma Nature Communications 2018 Aug 20;9(1):3327\n\nKruspig B, Monteverde T, Neidler S, Hock A, Kerr E, Nixon C, Clark W, Hedley A, Laing S, Coffelt SB, Le Quesne J, Dick C, Vousden K, Martins CP, Murphy DJ. The ERBB network facilitates KRAS-driven lung tumorigenesis Science Translational Medicine 2018 Jun 20;10(446):eaao2565\n\nAmelio I, Mancini M, Petrova V, Cairns RA, Vikhreva P, Nicolai S, Marini A, Antonov AA, Le Quesne J, Baena Acevedo JD, Dudek K, Sozzi G, Pastorino U, Knight RA, Mak TW, Melino G. p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression Proc Natl Acad Sci USA 2018 Nov 13;115(46):E10869-E10878\n\n2017\n\nKarekla E, 6. Liao WJ, Sharp B, Pugh J, Reid H, Le Quesne JP, Moore D, Pritchard CA, MacFarlane M, Pringle JH. Ex vivo explant cultures of non-small cell lung carcinoma enable evaluation of primary tumor responses to anticancer therapy Cancer Research 2017; 77:2029-2039\n\nJamal-Hanjani M, Wilson GA, McGranahan N, Birkbak NJ, Watkins TBK, Veeriah S, Shafi S, Johnson DH, Mitter R, Rosenthal R, Salm M, Horswell S, Escudero M, Matthews N, et al. Tracking the Evolution of Non-Small-Cell Lung Cancer New Engl J Med. 2017 Jun 1;376(22):2109-2121\n\nAbbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, et al. Phylogenetic ctDNA analysis depicts early stage lung cancer evolution Nature 2017 Apr 26;545(7655):446-451\n\nArce Vargas F, Furness AJS, Solomon I, Joshi K, Mekkaoui L, Lesko MH, Miranda Rota E, Dahan R, Georgiou A, et al. Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors Immunity 2017 Apr 18;46(4):577-86\n\nChernova T, Murphy F, Galavotti S, Sux X, Powley IR, Grosso S, Schinwald A, Zacarias-Cabeza J, Dudek K, Dinsdale D, Le Quesne J, Bennet J, Nakas A, Greaves P, Poland CA, Donaldson K, Bushell M, Willis AE, MacFarlane M. Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a/Arf) Current Biology 2017 Nov 6;27(21):3302-14.e6\n\nMcGranahan N, Rosenthal R, Hiley CT, Rowan AJ, Watkins TBK, Wilson GA, Birkbak NJ, Veeriah S, Van Loo P, Herrero J, Swanton C; TRACERx Consortium. Allele-specific HLA loss and immune escape in lung cancer evolution Cell 2017 Nov 30;171(6):1259-1271.e11\n\n2016\n\nHiley CT, Le Quesne J, Santis G, Sharpe R, de Castro DG, Middleton G, Swanton C. Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease The Lancet 2016 Sep 3;388(10048):1002-11\n\nBlows FM, Ali HR, Dawson SJ, Le Quesne J, Provenzano E, Caldas C, Pharoah PD. Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):221-6\n\nBusacca S, Law EW, Powley IR, Proia DA, Sequeira M, Le Quesne J, Klabatsa A, Edwards JM, Matchett KB, Luo JL, Pringle JH, El-Tanani M, MacFarlane M, Fennell DA. Resistance to HSP90 inhibition involving loss of MCL1 addiction Oncogene 2016 Mar 24;35(12):1483-92\n\nRecent Publications\n\n2023\n\nClarence T, Robert NSM, Sarigol F, Fu X, Bates PA, Simakov O. Robust 3D modeling reveals spatiosyntenic properties of animal genomes. iScience. 2023;26:106136.\n\nKato T, Jenkins RP, Derzsi S, Tozluoglu M, Rullan A, Hooper S, Chaleil RAG, Joyce H, Fu X, Thavaraj S, Bates PA, Sahai E. Interplay of adherens junctions and matrix proteolysis determines the invasive pattern and growth of squamous cell carcinoma. Elife. 2023;12.\n\nFu X, Sahai E, Wilkins A. Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response. The Journal of Pathology.2023;\n\n2022\n\nSchmidbaur H, Kawaguchi A, Clarence T, Fu X, Hoang OP, Zimmermann B, Ritschard EA, Weissenbacher A, Foster JS, Nyholm SV, Bates PA, Albertin CB, Tanaka E, Simakov O. Emergence of novel cephalopod gene regulation and expression through large-scale genome reorganization. Nat Commun. 2022;13:2172.\n\nFu X, Zhao Y, Lopez JI, Rowan A, Au L, Fendler A, Hazell S, Xu H, Horswell S, Shepherd STC, Spencer CE, Spain L, Byrne F, Stamp G, O'Brien T, Nicol D, Augustine M, Chandra A, Rudman S, Toncheva A, Furness AJS, Pickering L, Kumar S, Koh DM, Messiou C, Dafydd DA, Orton MR, Doran SJ, Larkin J, Swanton C, Sahai E, Litchfield K, Turajlic S, Bates PA. Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study. Nat Ecol Evol. 2022;6:88-102.\n\nFu X, Bates PA. Application of deep learning methods: From molecular modelling to patient classification. Exp Cell Res. 2022;418:113278.\n\n2021\n\nZhao Y, Fu X, Lopez JI, Rowan A, Au L, Fendler A, Hazell S, Xu H, Horswell S, Shepherd STC, Spain L, Byrne F, Stamp G, O'Brien T, Nicol D, Augustine M, Chandra A, Rudman S, Toncheva A, Pickering L, Sahai E, Larkin J, Bates PA, Swanton C, Turajlic S, Litchfield K. Selection of metastasis competent subclones in the tumour interior. Nat Ecol Evol. 2021;5:1033-1045.\n\nMuffoletto M, Qureshi A, Zeidan A, Muizniece L, Fu X, Zhao J, Roy A, Bates PA, Aslanidi O. Toward Patient-Specific Prediction of Ablation Strategies for Atrial Fibrillation Using Deep Learning. Front Physiol. 2021;12:674106.\n\nGerguri T, Fu X, Kakui Y, Khatri BS, Barrington C, Bates PA, Uhlmann F. Comparison of loop extrusion and diffusion capture as mitotic chromosome formation pathways in fission yeast. Nucleic Acids Res. 2021;49:1294-1312.\n\n2020\n\nKakui Y, Barrington C, Barry DJ, Gerguri T, Fu X, Bates PA, Khatri BS, Uhlmann F. Fission yeast condensin contributes to interphase chromatin organization and prevents transcription-coupled DNA damage. Genome Biol. 2020;21:272.\n\nAdhyapok P, Fu X, Sluka JP, Clendenon SG, Sluka VD, Wang Z, Dunn K, Klaunig JE, Glazier JA. A computational model of liver tissue damage and repair. PLoS One. 2020;15:e0243451.\n\n2019\n\nMuffoletto M, Fu X, Roy A, Varela M, Bates PA, Aslanidi OV. Development of a Deep Learning Method to Predict Optimal Ablation Patterns for Atrial Fibrillation. Paper presented at: 2019 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB); 9-11 July 2019, 2019.\n\nClendenon SG, Fu X, Von Hoene RA, Clendenon JL, Sluka JP, Winfree S, Mang H, Martinez M, Filson AJ, Klaunig JE, Glazier JA, Dunn KW. A simple automated method for continuous fieldwise measurement of microvascular hemodynamics. Microvasc Res. 2019;123:7-13.\n\nClendenon SG, Fu X, Von Hoene RA, Clendenon JL, Sluka JP, Winfree S, Mang H, Martinez M, Filson A, Klaunig JE, Glazier JA, Dunn KW. Spatial Temporal Analysis of Fieldwise Flow in Microvasculature. J Vis Exp. 2019;10.3791/60493.\n\n2018\n\nFu X, Sluka JP, Clendenon SG, Dunn KW, Wang Z, Klaunig JE, Glazier JA. Modeling of xenobiotic transport and metabolism in virtual hepatic lobule models. PLoS One. 2018;13:e0198060.\n\n2016\n\nFu X, Gens JS, Glazier JA, Burns S, Gast TJ. An Explanatory Computational Simulation of Contiguous Capillary Occlusion in Diabetic Retinopathy based on Patient-derived Vasculature. The FASEB Journal. 2016;30:555.551-555.551\n\nFu X, Sluka JP, Clendenon S, Glazier JA, Wang Z, Klaunig J, Ryan J, Dunn K. An in-Silico Model of Xenobiotic Distribution and Metabolism in a Simulated Mouse Hepatic Lobule. The FASEB Journal. 2016;30:1036.1038-1036.1038.\n\nSluka JP, Fu X, Swat M, Belmonte JM, Cosmanescu A, Clendenon SG, Wambaugh JF, Glazier JA. A Liver-Centric Multiscale Modeling Framework for Xenobiotics. PLoS One. 2016;11:e0162428.\n\nGast TJ, Fu X, Gens JS, Glazier JA. A Computational Model of Peripheral Photocoagulation for the Prevention of Progressive Diabetic Capillary Occlusion. J Diabetes Res. 2016;2016:2508381.\n\nFu X, Gens JS, Glazier JA, Burns SA, Gast TJ. Progression of Diabetic Capillary Occlusion: A Model. PLoS Comput Biol. 2016;12:e1004932."
    }
}